Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, J. W. Chapman, Lois E. Shepherd, Timothy J. Whelan, Bassam Mattar, José A. Bufill, William C. Schultz, Irving E. LaFrancis,

Breast Cancer Research and Treatment · 2018 · 95 citations · 20 references

DOIFull text

Open access

Concepts

References

20